Mental health conditions like depression, anxiety, ADHD, and bipolar disorder can have a major impact on a person’s quality of life. While psychotherapy and medication are common treatments, finding the right medication can be a challenge. The GeneSight Psychotropic Test is a pharmacogenomic test that helps healthcare providers select medications that are more likely to work based on a patient’s genetic makeup. Offered by Neuropsychiatric Clinic, this innovative test is now more affordable and accessible than ever before.

The GeneSight Test analyzes how variations in your genes affect your response to certain psychiatric medications. There are millions of variations that make each of us unique. Even small differences can impact how medications are processed in the body and how effective they will be. The test looks at genetic markers across 59 genes that provide medication guidance for: 

• Selective serotonin reuptake inhibitors (SSRIs) like Prozac, Zoloft, and Lexapro
• Serotonin–norepinephrine reuptake inhibitors (SNRIs) like Effexor and Cymbalta
• Atypical antipsychotics like Abilify, Seroquel, and Risperdal
• Typical antipsychotics like Haldol and Thorazine
• Mood stabilizers like lithium and Depakote
• ADHD medications like Adderall, Ritalin, and Strattera

Based on your test results, medications are categorized into three groups:

• Use as directed – More likely to work and have fewer side effects
• Use with caution – May require dosage adjustments or more monitoring
• Use with increased caution and with more frequent monitoring – Less likely to work and may have more side effects

This takes much of the guesswork out of prescribing and helps doctors select medications that are optimized based on each patient’s unique biology.

Numerous studies have shown that the GeneSight Test can lead to better patient outcomes when used to guide treatment. Potential benefits include:

• Fewer medication trial-and-error cycles
• Quicker relief of symptoms
• Better medication adherence
• Reduced risk of side effects
• Decreased healthcare utilization and costs

Patients who undergo GeneSight testing are twice as likely to respond to the first medication tried compared to those who undergo standard prescribing practices. They can expect to feel relief from symptoms in a shorter timeframe—typically within 2 weeks instead of the standard 6-8 weeks.

GeneSight testing also reduces the burden on the healthcare system. A two-year health economics study found that the test decreased hospitalization rates by 30-50%. Patients had 31% fewer emergency room visits and required 38% fewer follow-up appointments.

If you have struggled to find the right mental health medication, Genesight testing may be right for you. Work with your doctor or reach out to the Neuropsychiatric Clinic to learn more about the process and benefits. 

Our goal is to provide access to advanced genetic testing that can transform treatment approaches. With our reduced-price testing, GeneSight is more affordable than ever before – whether you have robust insurance coverage, minimal coverage, or no coverage at all. Schedule an appointment with us today to discuss your options.